1. MSB CHOSE to dual list on the NASDAQ. This isn't an inconvenience of someone else's making.
2. Did the need for more cash sneak up on SI? Really? Because that's how you've made it sound? Do you see MSB having any responsibility for MESO at all?
3. You are befriending a person that is ignorant and confused by that ignorance.
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-367
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
0.005(0.51%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 99.5¢ | $359.0K | 358.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 49689 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 31208 | 5 |
View Market Depth
| Last trade - 10.11am 25/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |